Faculty profile

Ramy Saleh

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Ramy Saleh

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
20 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Trial Design Clinical Trial Professional Clinical Trial Training Equity, Diversity, And Inclusion Best Practices Gender-Based Clinical Trial And Analysis Mentoring Platform Patient Partner Professional Education

Latest papers

A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report.
Frontiers in oncology · 2026
Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.
Cancer · 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Nature cancer · 2026

All 20 publications

Latest funding

Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum
CIHR · 2022 · Principal investigator
$10,855,234
Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum
CIHR · 2022 · Principal investigator
$2,829,331
Catalyzing research innovation: Developing a web-based application with social media capabilities to coordinate thrombosis research efforts
SSHRC · 2020 · Co-investigator
$250,000

All 4 grants and awards

20 publications.

A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report.

Onichino JR, Patel D, Powell T, Tsui JMG, Saleh R, Bozzo A

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1871862 PMID: 42761021

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Stacchiotti S, Blay JY, Rutkowski P, Gelderblom H, Falcón A, Le Cesne A, Desai J, Palmerini E, Serrano C, Ganjoo KN, D'Amato GZ, Ryan CW, Wilky BA, Ferraresi V, Saleh R, Ravi V, Razak AA, Herráez AC, Ahmed M, Bernthal NM, van de Sande M, Brahmi M, Szostakowski B, Sen J, Zeringo NA, Harrow B, Narasimhan S, Saunders A, Sharma MG, Sherman ML, Wagner AJ, Tap WD

Cancer2026

DOI: 10.1002/cncr.70564 PMID: 42643031

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Zemp FJ, Breckenridge Z, Song H, Gill GS, Louie TL, Narta K, Liu H, Suh Y, Guignard L, Mandujano-Tinoco EA, Collao N, Pyczek J, Ellestad KK, Curry J, Langley J, John C, Mah LK, Rajwani J, Evseev D, Turk M, Benaoudia S, Alex J, Naumenko V, Manoharan VT, Mehrabadi MK, Smith HA, Gilbert GNY, Gillmor A, Verhey TB, Todesco HM, Osz K, Ahn BY, Bogossian A, Anderson C, Sikdar S, Rukunuddin S, Bismar TA, Heng DYC, Lawson K, Linehan WM, Pedersen H, Gordon PMK, McIntyre JB, MacGregor J, Garzia L, Brodeur-Robb K, DiFrancesco L, Ogilvie T, Schöffski P, Wozniak A, Holt RA, Bell J, Senger DL, Lewis V, Monument M, Khan O, Baudrier L, Billon P, Gabriel V, Biernaskie J, Potts K, Trpkov K, Hay K, Quizi J, Chan J, Saleh R, Henning JW, Prokopishyn NL, Shafey M, Morrissy AS, Mahoney DJ

Nature cancer2026

DOI: 10.1038/s43018-026-01194-3 PMID: 42387022

Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab - A Case Report.

Faco Junior A, Salehi MA, Hodroj MH, Samanta R, Saleh R

Case reports in oncology2026Senior author

DOI: 10.1159/000553260 PMID: 42569788

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

Adile AA, Sran G, Bedard PL, Carlsson L, Doi J, Drummond-Ivars N, Hakgor S, Henderson A, Hilton JF, Josephy PD, Kremidas J, Limoges J, Renouf DJ, Ross F, Salawu A, Saleh R, Siu LL, Voccia I, Lewis HG, Paquette M, Razak ARA, Spreafico A

The oncologist2026

DOI: 10.1093/oncolo/oyag190 PMID: 42172621

Rhabdomyosarcoma Confined to the Bone Marrow: A Case Report and Literature Review.

Hodroj MH, Batrouni C, Faco Junior ADS, Salehi MA, Saleh R

Current oncology (Toronto, Ont.)2026Senior author

DOI: 10.3390/curroncol33060331 PMID: 42346231

Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial.

Xu H, Niu X, Ravi V, Martin-Broto J, Razak AA, Saleh R, Zhou Y, Shen J, Liu T, Sankhala KK, Serrano C, Stacchiotti S, Wang J, Baldi GG, Feng Y, Hua Y, Li T, Rutkowski P, Zhang X, Tinoco G, Zou Q, Shan B, Zhu X, Gelderblom H

Lancet (London, England)2026

DOI: 10.1016/s0140-6736(25)02602-9 PMID: 41796601

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Wittmann Dayagi T, Peretz Soroka H, Smrke A, Deyell RJ, Feng X, Oberoi S, Banerji S, Noujaim J, Prud'homme N, Saleh R, Khan OF, Bush JW, Marwa B, Watson G, Holloway C, Zhang L, Gupta AA, Brzezinski J

Cancer medicine2026

DOI: 10.1002/cam4.71495 PMID: 41554678

Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study

Bou-Nehme Sawaya G, Tanguay S, Wood LA, Kollmannsberger C, Basappa NS, Bansal R, Soulières D, Finelli A, Heng DYC, Castonguay V

Clinical Genitourinary Cancer20252 citations

DOI: 10.1016/j.clgc.2025.102342

KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.

De Meo ML, Seitlinger J, Rayes RF, Walsh LC, Shahzad MH, Tsering T, Saleh R, Ezer N, Shieh B, Wong A, Owen S, Walsh L, Fiset PO, Burnier JV, Spicer JD

Clinical lung cancer2025

DOI: 10.1016/j.cllc.2025.05.006 PMID: 40634198

Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms

Principal investigators: Bourbeau, Jean; Anderson, David R; Batist, Gerald; Bell, Emily C; Benoit, Britney L; Collister, David; Dasgupta, Kaberi; Fahim, Christine; Fergusson, Dean A; Filion, Kristian B; Gahagan, Jacqueline C; Goos, Lisa; Khan, Nadia A; King, Malcolm; Li, Linda C; Mitra, Souvik; Morin, Suzanne N; Pilote, Louise; Reiman, Tony; Richer, Lawrence P; Saleh, Ramy R; Sapp, John L; Tomblin Murphy, Gail G; Yeh, Ann E.

Keywords: Clinical Trial Design; Clinical Trial Professional; Clinical Trial Training; Equity, Diversity, And Inclusion Best Practices; Gender-Based Clinical Trial And Analysis; Mentoring Platform; Patient Partner; Professional Education; Research Involving Indigenous People; Training Platform

$10,855,234

Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms - Indirect Costs

$2,829,331

Catalyzing research innovation: Developing a web-based application with social media capabilities to coordinate thrombosis research efforts

Co-investigatorSSHRC2020New Frontiers in Research Fund - Exploration

Principal investigators: Skeith, Leslie

$250,000

Reducing post-discharge adverse drug events amongst the elderly: a multi-centre electronic deprescribing intervention

Co-investigatorCIHR2016Project Grant

Principal investigators: Lee, Todd C; McDonald, Emily G

Keywords: Adverse Drug Events; Choosing Wisely Canada; Deprescribing; Elderly; Frailty; High Value Healthcare; Medication Rationalization; Medication Stewardship; Polypharmacy

$1,662,789

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Clinical Trial Design Dear Professor Saleh, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Ramy Saleh

Research

Latest papers

Latest funding

A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report.

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab - A Case Report.

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

Rhabdomyosarcoma Confined to the Bone Marrow: A Case Report and Literature Review.

Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial.

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study

KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.

Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum

Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum

Catalyzing research innovation: Developing a web-based application with social media capabilities to coordinate thrombosis research efforts

Reducing post-discharge adverse drug events amongst the elderly: a multi-centre electronic deprescribing intervention

Frequent collaborators

Antonio Finelli

Aly-Khan Lalani

Alice Dragomir

Amirrtha Srikanthan

Christina Canil

Pierre-Olivier Fiset

Eric Winquist

Kevin Hay

Jan-Willem Henning

Jenny Godley

Jennifer Quizi

Jacqueline Limoges

Arielle Elkrief

Pierre Billon

Victor Lewis

Mona Shafey

Lorenzo Ferri

Jennifer Chan

Morag Park

Michael Monument

Aaron Pollett

Livia Garzia

Anna Spreafico

Logan Walsh

Marc Carrier

Leslie Skeith

Swneke Bailey

Wassim Kassouf

Nicole Ezer

Joel Werier

Teresa Chan

Morag Park